9.1 Refill Authority (Noncontrolled and CIII–V)
Key Takeaways
- CGS § 20-616(b) lets a pharmacist refill a prescription only on the prescriber’s written, oral, or electronically transmitted order, except the noncontrolled emergency refill in § 20-616(c) (once, not more than a 72-hour supply) and the diabetes-device path in subsection (d).
- CGS § 21a-249(h) bars filling or refilling a Schedule III or IV prescription more than six months after the date of issuance or more than five times unless the practitioner renews it; CGS § 21a-249(i) requires only a medical purpose for Schedule V.
- Federal 21 U.S.C. § 829 matches that split: CII no refills; CIII–IV five refills / six months; CV as authorized for a medical purpose. DCP’s practitioner FAQ has said five refills for III, IV, and V; DCP’s later prescribing materials and 2020 refill memo say CV is refilled as authorized — prefer the statute.
- RCSA § 20-576-39(b) lets a technician request authorization to renew an identical noncontrolled prescription if the supervising pharmacist knows the request is being made, the refill is identical in every element, and the pharmacist reviews the authorization before it is used.
- CGS § 20-614 allows “PRN” and “ad lib” on noncontrolled prescriptions in lieu of a number; those words do not override the CIII–IV five-refill / six-month ceiling, and they do not create an infinite noncontrolled prescription when the practitioner never authorized ongoing therapy.
Why refill clocks are a high-yield MPJE skill
Quick Answer: Refill a noncontrolled prescription as the practitioner authorized. CGS § 20-616 does not publish a one-year outer expiration for those refills. Schedule II cannot be refilled. CGS § 21a-249(h) — matching 21 U.S.C. § 829(b) — says a Schedule III or IV prescription shall not be filled or refilled more than six months after the date thereof or be refilled more than five times, unless renewed. Schedule V is not in that sentence; § 21a-249(i) requires only a medical purpose. RCSA § 20-576-39(b) lets a technician request an identical noncontrolled renewal authorization that the supervising pharmacist reviews.
NABP Competency 2.1.5 tests refill authority. Connecticut answers with Chapter 400j for legend drugs and Chapter 420b plus the federal Controlled Substances Act for scheduled drugs. Mixing those stacks is how a candidate treats “PRN Xanax” like “PRN lisinopril,” or lets a technician call for an alprazolam refill as if it were a blood-pressure tablet.
Noncontrolled prescriptions — as authorized, not as assumed
CGS § 20-616(b) is the default: except as provided in subsections (c) or (d), a prescription may be refilled only upon the written, oral, or electronically transmitted order of a prescribing practitioner. That order can be the refill number written on the original prescription, or a later authorization. If the original prescription is silent on refills, Connecticut does not treat silence as a free first refill. Silence is zero authorized refills until the practitioner orders one.
CGS § 20-614 requires the pharmacy record of an oral or electronic noncontrolled prescription, and the face of a written prescription, to include the number of times the prescription may be refilled, including the use of refill terms “PRN” and “ad lib” in lieu of a specific number of authorized refills. Those two words are legal on noncontrolled prescriptions. They are not a license to refill forever without pharmacist judgment, and they are not a way around controlled-substance ceilings.
PRN / ad lib pitfalls on the exam:
- PRN lisinopril means the practitioner authorized refills as needed for that therapy. § 20-616 still requires that the original (or a later) order actually used those terms or a number. The pharmacist still screens for a stale therapy, a dose change, or a patient who has not been seen in years. What Connecticut has not published in § 20-616 is a hard one-year (or other) outer expiration for noncontrolled refill validity. Unless a Connecticut statute or regulation sets an outer limit, noncontrolled refill validity is as authorized. Do not import another state’s “one year from the written date” rule into a Connecticut stem unless the stem itself cites such a rule.
- PRN alprazolam is not an open refill. Alprazolam is Schedule IV. § 21a-249(h) and 21 U.S.C. § 829(b) cap it at five refills and six months, whichever comes first, unless the practitioner renews the prescription. “PRN” on a CIII–IV blank does not add a sixth refill or stretch month seven.
- Ad lib on a CII is a void refill instruction. No prescription for a Schedule II controlled substance may be refilled (21 U.S.C. § 829(a); 21 CFR 1306.12; CGS § 21a-250 permits filling or refilling only as federal CSA and Connecticut law allow).
Emergency and quantity tools that are not extra refill authorizations
Two Chapter 400j tools sit next to refill authority and get confused with it.
CGS § 20-616(c) — emergency refill without the prescriber’s authorization — applies only to a prescription that is not for a controlled drug. All three conditions must be true: (1) the pharmacist cannot contact the practitioner after reasonable effort; (2) failure to refill might interrupt a therapeutic regimen or create patient suffering; and (3) the pharmacist tells the patient (or representative) at dispensing that this fill is unauthorized, and tells the practitioner at the earliest reasonable time that authorization is required for future refills. The statute then limits the act: the prescription may be refilled once under this subsection, for not more than a 72-hour supply. It is not a 30-day courtesy, it is not available for oxycodone or clonazepam, and it does not create remaining refills on the original prescription.
CGS § 20-616(d) is a diabetes path (insulin, glucagon, ketoacidosis devices, and related devices) of up to a 30-day pharmacist-prescribed supply when statutory criteria are met. That is a new pharmacist prescription, not a refill of the old one. Do not use it as a general emergency-refill expansion.
CGS § 20-616a is a quantity rule, not a refill-count rule. After the initial quantity has been dispensed, a pharmacist may, using professional judgment, refill a greater quantity than the original fill — up to a 90-day supply, never more than the total quantity the practitioner authorized, never a controlled drug, never against a prescriber notation forbidding a quantity change, with notice to the practitioner within 48 hours, and only if the patient’s insurance will cover that quantity without extra out-of-pocket cost. Combining remaining 30-day fills of a noncontrolled maintenance drug into a 90-day bottle is § 20-616a. Inventing a sixth CIII refill is not.
Schedule III, IV, and V — read subsection (h) and subsection (i) separately
CGS § 21a-249(h) is specific: except when a practitioner (other than a pharmacy) dispenses directly to an ultimate user, a Schedule III or IV controlled substance that is a prescription drug shall not be dispensed without a written, electronically transmitted, or oral prescription, and the prescription shall not be filled or refilled more than six months after the date thereof or be refilled more than five times, unless renewed by the practitioner. Both limits apply. Five refills used in month two still leave a dead prescription in month seven. Zero refills used still leave a dead prescription the day after six months. “Renewed” means a new prescription, not a technician scribbling “+5” on the old one.
CGS § 21a-249(i) then treats Schedule V in a different sentence: a CV shall not be distributed or dispensed other than for a medical purpose. There is no six-month / five-refill clause in (i). Federal law is the same split: 21 U.S.C. § 829(b) puts the five-refill / six-month cap on III and IV; § 829(c) requires only a medical purpose for V. 21 CFR 1306.22 implements the III–IV refill record rules.
Reconcile DCP’s FAQ. DCP’s Controlled Substance Registration for Practitioner FAQ (Question 3) states: “A maximum of five refills are permitted for Schedule III, IV, and V medications.” That sentence lumps V with III and IV. It is not how § 21a-249 is written. DCP’s 2020 refill/reissuance memo and DCP’s later Prescribing Controlled Substances practitioner PDF both restore the statutory split: CIII and CIV may be refilled up to five times in six months as authorized; CV may be refilled as authorized by the prescribing practitioner. On the MPJE, prefer the current statute. If a stem quotes the practitioner FAQ, know that DCP has also published the five-refill line for V; the more specific, later DCP prescribing materials and CGS § 21a-249(i) do not impose that cap. Do not invent a Connecticut CV six-month statute that does not exist.
| Schedule | Refills | Outer clock | Principal authority |
|---|---|---|---|
| Noncontrolled legend | As the practitioner authorized (number, PRN, or ad lib) | No one-year (or other) outer expiration is published in § 20-616; validity is as authorized unless a Connecticut rule sets a limit | CGS §§ 20-614, 20-616 |
| Schedule II | None | Not a refill problem; new prescription required each time (multiple CII prescriptions under 21 CFR 1306.12 are not refills) | 21 U.S.C. § 829(a); 21 CFR 1306.12; CGS § 21a-250 |
| Schedule III or IV | Not more than five, and only as authorized | Not filled or refilled more than six months after the issuance date, unless renewed | CGS § 21a-249(h); 21 U.S.C. § 829(b) |
| Schedule V | As authorized for a medical purpose | No five-refill / six-month sentence in § 21a-249(i) or 21 U.S.C. § 829(c); DCP FAQ has said five for V — prefer the statute and later DCP prescribing text | CGS § 21a-249(i); DCP FAQ vs DCP prescribing PDF |
Technicians may request identical noncontrolled renewal — they do not grant it
RCSA § 20-576-39(a) still forbids technicians from receiving new verbal orders, counseling, interpreting prescriptions, consulting the prescriber about medical information, verifying a prescription before release, or selecting a generic. Subsection (b) then carves a refill-request exception, and only that exception:
- The communication is to obtain authorization for the renewal of an existing prescription for a drug other than a controlled substance that can no longer be refilled.
- The supervising pharmacist is aware that the authorization is being requested.
- The refill being requested is identical to the original prescription — no change in the prescribed drug, strength, form, quantity, dose, route, or any other element.
- All refill authorizations the technician obtains are reviewed by the supervising pharmacist to ensure there is no change.
A dose change, a switch from tablets to capsules, an added PRN, or any controlled substance (including CV) knocks the technician out of § 20-576-39(b). The pharmacist takes that call. Chapter 4 covers the rest of the technician prohibitions; this chapter only needs the refill-authorization slice.
Realistic Connecticut scenarios
A New Haven patient presents a six-month-old lisinopril prescription marked “PRN.” § 20-616 does not kill it solely because six months have passed. The pharmacist still confirms that the practitioner actually authorized ongoing PRN refills and that nothing in the profile makes the therapy unreasonable. The same date on a clonazepam prescription is a hard stop under § 21a-249(h) unless the practitioner has renewed it.
A technician at a Bridgeport chain calls a cardiology office for “another year of the same metoprolol, identical in every field,” after the original refill count is exhausted. The pharmacist on duty knows the call is being made. The office returns “same drug, same SIG, same quantity, three refills.” The pharmacist reviews that authorization before it is dispensed. That is § 20-576-39(b). The same technician calling for identical zolpidem is outside the regulation because zolpidem is controlled.
A Saturday lisinopril patient is out of tablets, the office is closed, and stopping the drug would interrupt therapy. After a reasonable effort to reach the prescriber, the pharmacist may dispense one 72-hour supply under § 20-616(c) and must tell both the patient and, as soon as reasonable, the practitioner. Offering a 30-day bottle “as a courtesy” is not the statute.
Official anchors
- CGS § 20-616 — refill only on the practitioner’s order; 72-hour noncontrolled emergency refill; diabetes 30-day path.
- CGS § 20-616a — 90-day noncontrolled quantity on refill, after the initial fill, with conditions.
- CGS § 21a-249 — subsection (h) CIII–IV six months / five refills; subsection (i) CV medical purpose.
- RCSA § 20-576-39 — technician identical noncontrolled renewal requests; pharmacist review.
- DCP practitioner CS FAQ — FAQ that states five refills for III, IV, and V; reconcile with the statute.
A Hartford pharmacy holds a written prescription for clonazepam 0.5 mg, a Schedule IV drug, issued January 10 with five refills authorized. The patient used no refills. On July 20 of the same year the patient asks for a refill. Which statement is correct under CGS § 21a-249(h)?
Under RCSA § 20-576-39(b), when may a Connecticut pharmacy technician communicate with a prescriber’s office to obtain refill authorization?
A Waterbury patient is out of a noncontrolled maintenance drug on a Saturday. The original prescription has no remaining refills. After a reasonable effort the pharmacist cannot reach the prescriber, and missing doses would interrupt therapy. What does CGS § 20-616(c) allow?